D.E. Shaw & Co’s Zimmer Biomet ZBH Stock Holding History

D.E. Shaw & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	+22,400	New	+$1.96M	﹤0.01%	3237
2026 Q1	–	Sell	-25,100	Closed	-$2.26M	–	5140
2025 Q4	$2.26M	Buy	+25,100	New	+$2.38M	﹤0.01%	2956
2022 Q4	–	Sell	-25,000	Closed	-$2.61M	–	5170
2022 Q3	$2.61M	Hold	25,000	–	–	﹤0.01%	2752
2022 Q2	$2.63M	Hold	25,000	–	–	﹤0.01%	2825
2022 Q1	$3.2M	Sell	25,000 -750	-3%	-$90.4K	﹤0.01%	2816
2021 Q4	$3.18M	Buy	+25,750	New	+$3.37M	﹤0.01%	2896
2019 Q2	–	Sell	-13,905	Closed	-$1.72M	–	3916
2019 Q1	$1.72M	Buy	+13,905	New	+$1.58M	﹤0.01%	2264
2017 Q2	–	Sell	-10,300	Closed	-$1.22M	–	3570
2017 Q1	$1.22M	Buy	+10,300	New	+$1.17M	﹤0.01%	2174
2014 Q4	–	Sell	-10,300	Closed	-$1.01M	–	4294
2014 Q3	$1.01M	Sell	10,300 -6,901	-40%	-$679K	﹤0.01%	2807
2014 Q2	$1.73M	Buy	+17,201	New	+$1.68M	﹤0.01%	2424
2014 Q1	–	Sell	-70,761	Closed	-$6.4M	–	4679
2013 Q4	$6.4M	Sell	70,761 -40,582	-36%	-$3.51M	0.01%	1476
2013 Q3	$8.88M	Hold	111,343	–	–	0.01%	1109
2013 Q2	$8.1M	Buy	+111,343	New	+$8.33M	0.02%	1009

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co's ZBH Position: Q2 2026 in Review

D.E. Shaw & Co increased its Zimmer Biomet (ZBH) stake by 164% in Q2 2026, buying an estimated $1.31M and bringing the position to 24,120 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

D.E. Shaw & Co first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $156M in Q4 2015. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

D.E. Shaw & Co held 24,120 shares of Zimmer Biomet worth $2.08M as of Q2 2026.
D.E. Shaw & Co bought 14,974 Zimmer Biomet shares in Q2 2026, an estimated $1.31M.
Zimmer Biomet made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3171 holding.
D.E. Shaw & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
D.E. Shaw & Co's Zimmer Biomet position peaked at $156M in Q4 2015.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.